BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Clinical trials for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA trials appear
Sign up with your email to follow new studies for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
PET scans guide new combo therapy to fight returning prostate cancer
Disease control Recruiting nowThis Phase III trial is testing whether using PET scans to guide treatment can help men whose prostate cancer has returned after surgery. For those without signs of spread outside the pelvis, researchers are adding a drug called apalutamide (plus other hormones) to standard radia…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New trial aims to Fine-Tune prostate cancer treatment timing
Disease control Recruiting nowThis study looks at the best timing for combining targeted radiation (SBRT) with hormone therapy in men whose prostate cancer has returned and spread. It also tests if radiation to the pelvis can stop cancer from spreading further. About 532 men with recurrent, hormone-sensitive …
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation method (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for men whose prostate cancer has come back or spread to a few spots after surgery. About 118 participants will receive o…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could home cancer care be better? new trial for black men with prostate cancer
Symptom relief Recruiting nowThis study compares giving standard prostate cancer treatment at home versus in a clinic for Black men with advanced or metastatic prostate cancer. The goal is to see if home treatment improves patient satisfaction, safety, and reduces stress. Thirty-eight participants will recei…
Matched conditions: BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC